Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Interleukin-1 receptor antagonist as a biomarker of sepsis in neutropenic haematological patients.

Intke C, Korpelainen S, Hämäläinen S, Vänskä M, Koivula I, Jantunen E, Pulkki K, Juutilainen A.

Eur J Haematol. 2018 Aug 12. doi: 10.1111/ejh.13161. [Epub ahead of print]

PMID:
30099772
2.

Novel Biomarker Candidates for Febrile Neutropenia in Hematological Patients Using Nontargeted Metabolomics.

Lappalainen M, Jokkala J, Juutilainen A, Hämäläinen S, Koivula I, Jantunen E, Hanhineva K, Pulkki K.

Dis Markers. 2018 Apr 12;2018:6964529. doi: 10.1155/2018/6964529. eCollection 2018.

3.

Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.

Rönkkö R, Juutilainen A, Koivula I, Vänskä M, Nousiainen T, Jantunen E, Hämäläinen S.

Infect Dis (Lond). 2018 Jun;50(6):436-442. doi: 10.1080/23744235.2017.1420221. Epub 2018 Jan 5.

PMID:
29303041
4.

Old enemies in new disguises: emergence of Enterococcus faecium as a significant clinical problem at an adult haematology ward.

Hämäläinen S, Pentikäinen J, Reijula J, Mauranen E, Koivula I, Lindholm L, Juutilainen A, Nousiainen T, Pyörälä M, Vuopio J, Jantunen E.

Infect Dis (Lond). 2017 Aug;49(8):628-631. doi: 10.1080/23744235.2017.1296969. Epub 2017 Mar 3. No abstract available.

PMID:
28276797
5.

Asymmetric dimethylarginine in the assessment of febrile neutropenia in hematological patients.

Lappalainen M, Hämäläinen S, Juutilainen A, Koivula I, Pulkki K, Jantunen E.

Scand J Clin Lab Invest. 2017 Apr;77(2):130-134. doi: 10.1080/00365513.2017.1286518.

PMID:
28218011
6.

[Herpes zoster in the pharynx].

Sipari S, Koivula I, Löppönen H.

Duodecim. 2016;132(8):735-9. Finnish.

PMID:
27244933
7.

Biomarkers of neutropenic sepsis.

Jantunen E, Juutilainen A, Hämäläinen S, Koivula I, Vänskä M, Purhonen AK, Pulkki K.

Duodecim. 2016;132(21):1946-51. Review.

PMID:
29190045
8.

Human plasma cell-free DNA as a predictor of infectious complications of neutropenic fever in hematological patients.

Purhonen AK, Juutilainen A, Vänskä M, Lehtikangas M, Lakkisto P, Hämäläinen S, Koivula I, Jantunen E, Pulkki K.

Infect Dis (Lond). 2015 Apr;47(4):255-9. doi: 10.3109/00365548.2014.985711. Epub 2015 Feb 9.

PMID:
25664374
9.

Transmission of Streptococcus equi subspecies zooepidemicus infection from horses to humans.

Pelkonen S, Lindahl SB, Suomala P, Karhukorpi J, Vuorinen S, Koivula I, Väisänen T, Pentikäinen J, Autio T, Tuuminen T.

Emerg Infect Dis. 2013 Jul;19(7):1041-8. doi: 10.3201/eid1907.121365.

10.

Soluble form of urokinase-type plasminogen activator receptor as a diagnostic and prognostic marker in hematological patients with neutropenic fever.

Vänskä M, Purhonen AK, Koivula I, Jantunen E, Hämäläinen S, Pulkki K, Juutilainen A.

Leuk Lymphoma. 2014 Mar;55(3):718-21. doi: 10.3109/10428194.2013.811582. Epub 2013 Jul 22. No abstract available.

PMID:
23734690
11.

[Mycoplasma pneumoniae and Stevens-Johnson syndrome].

Väisänen T, Hämäläinen S, Koivula I, Koskela H.

Duodecim. 2012;128(21):2272-6. Finnish.

PMID:
23210290
12.

IL-10 combined with procalcitonin improves early prediction of complications of febrile neutropenia in hematological patients.

Vänskä M, Koivula I, Jantunen E, Hämäläinen S, Purhonen AK, Pulkki K, Juutilainen A.

Cytokine. 2012 Dec;60(3):787-92. doi: 10.1016/j.cyto.2012.07.023. Epub 2012 Aug 17.

PMID:
22902948
13.

Plasma copeptin in the assessment of febrile neutropenia.

Purhonen AK, Vänskä M, Hämäläinen S, Pulkki K, Lehtikangas M, Kuittinen T, Nousiainen T, Koivula I, Jantunen E, Juutilainen A.

Peptides. 2012 Jul;36(1):129-32. doi: 10.1016/j.peptides.2012.05.001. Epub 2012 May 11.

PMID:
22580173
14.

High pentraxin 3 level predicts septic shock and bacteremia at the onset of febrile neutropenia after intensive chemotherapy of hematologic patients.

Vänskä M, Koivula I, Hämäläinen S, Pulkki K, Nousiainen T, Jantunen E, Juutilainen A.

Haematologica. 2011 Sep;96(9):1385-9. doi: 10.3324/haematol.2011.044925.

15.

Biomarkers for bacteremia and severe sepsis in hematological patients with neutropenic fever: multivariate logistic regression analysis and factor analysis.

Juutilainen A, Hämäläinen S, Pulkki K, Kuittinen T, Nousiainen T, Jantunen E, Koivula I.

Leuk Lymphoma. 2011 Dec;52(12):2349-55. doi: 10.3109/10428194.2011.597904. Epub 2011 Jul 14.

PMID:
21756036
16.

Procalcitonin is a useful marker of infection in neutropenia.

Koivula I, Juutilainen A.

Leuk Res. 2011 Oct;35(10):1288-9. doi: 10.1016/j.leukres.2011.06.014. Epub 2011 Jul 13. No abstract available.

PMID:
21742379
17.

Pentraxin 3 predicts complicated course of febrile neutropenia in haematological patients, but the decision level depends on the underlying malignancy.

Juutilainen A, Vänskä M, Pulkki K, Hämäläinen S, Nousiainen T, Jantunen E, Koivula I.

Eur J Haematol. 2011 Nov;87(5):441-7. doi: 10.1111/j.1600-0609.2011.01666.x. Epub 2011 Aug 15.

PMID:
21676033
18.

Serum cortisol and inflammatory response in neutropenic fever.

Juutilainen A, Hämäläinen S, Niemenpää J, Kuittinen T, Pulkki K, Koivula I, Niskanen L, Jantunen E.

Ann Hematol. 2011 Dec;90(12):1467-75. doi: 10.1007/s00277-011-1211-6. Epub 2011 Mar 25.

PMID:
21437589
19.

Elevated procalcitonin predicts Gram-negative sepsis in haematological patients with febrile neutropenia.

Koivula I, Hämäläinen S, Jantunen E, Pulkki K, Kuittinen T, Nousiainen T, Juutilainen A.

Scand J Infect Dis. 2011 Jul;43(6-7):471-8. doi: 10.3109/00365548.2011.554855. Epub 2011 Feb 7.

PMID:
21299364
20.

Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007.

Poikonen E, Lyytikäinen O, Anttila VJ, Koivula I, Lumio J, Kotilainen P, Syrjälä H, Ruutu P.

BMC Infect Dis. 2010 Oct 28;10:312. doi: 10.1186/1471-2334-10-312.

21.

Serum amino-terminal pro-brain natriuretic peptide in hematological patients with neutropenic fever: a prospective comparison with C-reactive protein.

Hämäläinen S, Juutilainen A, Kuittinen T, Nousiainen T, Matinlauri I, Pulkki K, Koivula I, Jantunen E.

Leuk Lymphoma. 2010 Jun;51(6):1040-6. doi: 10.3109/10428191003743478.

PMID:
20470220
22.

Serial plasma lactate measurements in haematological patients with neutropenic fever.

Juutilainen A, Hämäläinen S, Matinlauri I, Kuittinen T, Nousiainen T, Pulkki K, Koivula I, Jantunen E.

Scand J Infect Dis. 2010;42(2):102-8. doi: 10.3109/00365540903338113.

PMID:
19883163
23.

Deep, respiratory tract and ear infections caused by Pseudallescheria (Scedosporium) and Microascus (Scopulariopsis) in Finland. A 10-year retrospective multi-center study.

Issakainen J, Salonen JH, Anttila VJ, Koukila-Kähkölä P, Castrén M, Liimatainen O, Vuento R, Ojanen T, Koivula I, Koskela M, Meurman O.

Med Mycol. 2010 May;48(3):458-65. doi: 10.1080/13693780903161208.

PMID:
19672782
24.

Serum vascular endothelial growth factor in adult haematological patients with neutropenic fever: a comparison with C-reactive protein.

Hämäläinen S, Juutilainen A, Matinlauri I, Kuittinen T, Ruokonen E, Koivula I, Jantunen E.

Eur J Haematol. 2009 Sep;83(3):251-7. doi: 10.1111/j.1600-0609.2009.01260.x. Epub 2009 Mar 19.

PMID:
19302556
25.

Severe sepsis in autologous stem cell transplant recipients: microbiological aetiology, risk factors and outcome.

Hamalainen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E.

Scand J Infect Dis. 2009;41(1):14-20. doi: 10.1080/00365540802454706.

PMID:
18836947
26.

Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.

Hämäläinen S, Kuittinen T, Matinlauri I, Nousiainen T, Koivula I, Jantunen E.

Leuk Lymphoma. 2008 Mar;49(3):495-501. doi: 10.1080/10428190701809172.

PMID:
18297526
27.

Kivikasvoisen miehen hengenahdistus.

Hämäläinen S, Koivula I.

Duodecim. 2007;123(15):1879-80. Finnish. No abstract available.

PMID:
18020270
28.

A retrospective nationwide case study on the use of a new antifungal agent: patients treated with caspofungin during 2001-2004 in Finland.

Anttila VJ, Salonen J, Ylipalosaari P, Koivula I, Riikonen P, Nikoskelainen J.

Clin Microbiol Infect. 2007 Jun;13(6):606-12. Epub 2007 Jan 22.

29.

Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.

Ruotsalainen E, Järvinen A, Koivula I, Kauma H, Rintala E, Lumio J, Kotilainen P, Vaara M, Nikoskelainen J, Valtonen V; Finlevo Study Group.

J Intern Med. 2006 Feb;259(2):179-90.

30.

[Aplasia of the inferior vena cava as a cause of recurring thrombosis in a young man].

Karhapää P, Kaukanen E, Koivula I, Lassila R.

Duodecim. 2004;120(4):402-7. Finnish. No abstract available.

PMID:
15065458
31.

Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study.

Koivula I, Stén M, Mäkelä PH.

Arch Intern Med. 1999 Jul 26;159(14):1550-5.

PMID:
10421277
32.

Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial.

Koivula I, Stén M, Leinonen M, Mäkelä PH.

Am J Med. 1997 Oct;103(4):281-90.

PMID:
9382120
33.

Effect of immunosuppressive therapy on the clinical presentation of legionellosis.

Skogberg K, Ruutu P, Koivula I, Jousimies-Somer H, Valtonen V.

Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):535-41.

PMID:
7805680
34.

Risk factors for pneumonia in the elderly.

Koivula I, Sten M, Mäkelä PH.

Am J Med. 1994 Apr;96(4):313-20.

PMID:
8166149
35.

[Persistent ear infection, impaired hearing and fever].

Jantunen E, Koivula I.

Duodecim. 1994;110(19):1797-9. Finnish. No abstract available.

PMID:
7555776
36.

[Tuberculosis in the cervical spine of a young woman].

Pettilä V, Koivula I, Myllynen P.

Duodecim. 1991;107(14):1162-6. Finnish. No abstract available.

PMID:
1670514
37.

[Aspergillus infections in patients suffering from malignant blood diseases].

Koivula I, Jantunen E, Nousiainen T, Lahtinen R, Jokinen C.

Duodecim. 1991;107(3):167-72. Finnish. No abstract available.

PMID:
1364754
38.

[Chronic fatigue symptoms--a new syndrome associated with persistent exhaustion].

Koivula I, Soppi E.

Duodecim. 1989;105(13-14):1260-5. Review. Finnish. No abstract available.

PMID:
2548825
39.

Effect of rifampicin treatment on the kinetics of mexiletine.

Pentikäinen PJ, Koivula IH, Hiltunen HA.

Eur J Clin Pharmacol. 1982;23(3):261-6.

PMID:
6129140

Supplemental Content

Loading ...
Support Center